BioPlus Acquisition Statistics Share Statistics BioPlus Acquisition has n/a
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 11.23M Failed to Deliver (FTD) Shares 100 FTD / Avg. Volume 0.28%
Short Selling Information The latest short interest is 1.79K, so 0% of the outstanding
shares have been sold short.
Short Interest 1.79K Short % of Shares Out n/a Short % of Float 0.01% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 1183.31 and the forward
PE ratio is null.
BioPlus Acquisition's PEG ratio is
-8.53.
PE Ratio 1183.31 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 27.4 P/FCF Ratio -8835.49 PEG Ratio -8.53
Financial Ratio History Enterprise Valuation BioPlus Acquisition has an Enterprise Value (EV) of 6.11B.
EV / Sales 0 EV / EBITDA -5221.43 EV / EBIT -8842.52 EV / FCF -8842.52
Financial Position The company has a current ratio of 1.04,
with a Debt / Equity ratio of 0.02.
Current Ratio 1.04 Quick Ratio 1.04 Debt / Equity 0.02 Debt / EBITDA -4.27 Debt / FCF -7.23 Interest Coverage 0
Financial Efficiency Return on Equity is 2.32% and Return on Invested Capital is -1.27%.
Return on Equity 2.32% Return on Assets 2.17% Return on Invested Capital -1.27% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -3.17M Effective Tax Rate -158.67%
Stock Price Statistics The stock price has increased by -0.09% in the
last 52 weeks. The beta is 0, so BioPlus Acquisition's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change -0.09% 50-Day Moving Average 10.77 200-Day Moving Average 10.54 Relative Strength Index (RSI) 51.09 Average Volume (20 Days) 35,934
Income Statement
Revenue n/a Gross Profit -1.17M Operating Income -1.17M Net Income 5.16M EBITDA -1.17M EBIT n/a Earnings Per Share (EPS) 0.01
Full Income Statement Balance Sheet The company has 140.3K in cash and 5M in
debt, giving a net cash position of -4.86M.
Cash & Cash Equivalents 140.3K Total Debt 5M Net Cash -4.86M Retained Earnings -14.78M Total Assets 138.63M Working Capital -1.78M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -691.47K
and capital expenditures 0, giving a free cash flow of -691.47K.
Operating Cash Flow -691.47K Capital Expenditures n/a Free Cash Flow -691.47K FCF Per Share 0
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
